Camber Capital Management »

10x Genomics Inc Cl A shares owned by Camber Capital Management

Quarter-by-quarter ownership of 10x Genomics Inc Cl A (TXG) shares owned by Camber Capital Management from 13F filings

Historical chart of Camber Capital Management investment in 10x Genomics Inc Cl A

Tip: Access up to 7 years of quarterly data

All positions including 10x Genomics Inc Cl A held by Camber Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in 10x Genomics Inc Cl A by Camber Capital Management

Quarter filed Position value Share count Share price at filing
2025-03-31 $8.7M 1.0M 8.73
2024-12-31 $14M 1.0M 14.36

More positions owned by Camber Capital Management

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Zimmer Holdings (ZBH)
Baxter International (BAX)
Humana (HUM)
CVS Caremark Corporation (CVS)
Globus Med Cl A (GMED)
Icon SHS (ICLR)
Ascendis Pharma A/s Sponsored Adr (ASND)
Merck & Co (MRK)
GSK Sponsored Adr Call Option (GSK)
Pfizer (PFE)
BioMarin Pharmaceutical (BMRN)
UnitedHealth (UNH)
Viatris (VTRS)
Brookdale Senior Living (BKD)

View all positions for Camber Capital Management

Top funds holding 10x Genomics Inc Cl A

Vanguard Group
ARK Investment Management
BlackRock
FMR
Millennium Management
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
Wellington Management Company
Quantinno Capital Management
Morgan Stanley
Jacobs Levy Equity Management
AQR Capital Management
Geode Capital Management
Goldman Sachs Group
State Street Corporation

View all funds holding 10x Genomics Inc Cl A